Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Mankato-North Mankato, MN MSA — September 2026
Mankato job growth stalls as talent pool keeps shrinking.
Mankato added just 100 jobs in August after 500 in July, while Minnesota's labor-force participation rate fell to 66.9% — a tightening backdrop that pushes Life Sci employers toward Twin Cities-anchored compensation benchmarks.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Mankato unemployment rate: 3.9% — vs 4.1% national, 4.4% Minnesota (July 2026)
- Mankato job growth, August: +100 jobs — Down from +500 in July 2026
- MN labor-force participation: 66.9% — Down from 68.1% a year earlier
- Minnesota WARN-affected workers: 1,473 in 2026 — Down 69% from 2025 levels
Key takeaways
Mankato's job growth is stalling, not reversing.
August's 100-job gain follows July's 500, a deceleration that tracks Minnesota's flat statewide employment growth rather than metro-specific weakness. Life Sci employers should not read this as loosening talent supply — unemployment at 3.9% remains tighter than national and state rates.
Lab Technician pay is rising locally while falling nationally.
Metro median advertised pay of $42,053 moved up this month even as the national median of $47,402 declined, a divergence that suggests Mankato employers are competing harder for entry-to-mid-level lab talent precisely as national demand cools. This narrowing gap may reduce the cost advantage of a smaller metro for routine lab roles.
Twin Cities proximity is Mankato's real talent strategy.
Minneapolis-St. Paul's 16% share of national medtech talent and above-average regional salaries mean Mankato-based organizations are effectively competing in a Twin Cities labor shed for regulatory, quality, and CMC hires. Compensation benchmarking anchored only to local averages risks systematically underpricing these roles.
Demographic drag may outlast the current hiring slowdown.
Falling statewide labor-force participation and declining in-migration are structural, not cyclical, pressures on Minnesota's talent pipeline. Headcount planning for specialized functions should assume supply constraints persist even if broader job growth reaccelerates.
Median advertised pay by role — Mankato-North Mankato, MN MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $112,086 | $145,000 | $160,197 | Significant increase | $131,354 |
| Clinical Research Associate * | $68,654 | $98,509 | $111,992 | Significant increase | $90,956 |
| Lab Technician | $40,081 | $42,053 | $42,347 | Moderate increase | $47,402 |
| Regulatory Affairs Specialist * | $86,969 | $115,000 | $124,483 | Moderate increase | $104,000 |
| Clinical Data Manager * | $90,999 | $116,835 | $123,807 | Significant increase | $123,031 |
| Biostatistician * | $103,789 | $129,425 | $148,000 | Stable | $133,322 |
| Validation Engineer * | $88,889 | $107,806 | $112,183 | Moderate increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Mankato's 3.9% July unemployment rate sits well below the national 4.1% and Minnesota's statewide 4.4%, but the metro's modest 100-job gain in August — a sharp deceleration from July's 500-job add — points to a labor market that has stopped loosening without meaningfully tightening further. Statewide labor-force participation has fallen every month of 2026 to 66.9%, and DEED's own commissioner has flagged an aging workforce and slowing in-migration as structural constraints that compound scarcity for credential-heavy life sciences roles outside the Twin Cities talent base.
What it means
A metro this small cannot organically supply specialized regulatory, quality, or CMC talent — Minneapolis-St. Paul's 16% share of national medtech talent makes it the de facto bench for Mankato-based employers, meaning compensation benchmarking should track Twin Cities advertised pay movements, not just local averages. With lab/R&D vacancy running above 23% nationally even as biotech R&D employment hits record levels, build-vs-outsource tradeoffs tilt further toward CRO/CDMO partnerships for roles Mankato cannot realistically staff at scale. Consider reviewing whether current total rewards packages for regulatory and CMC functions reflect Twin Cities commuting-distance competition rather than Mankato MSA's $30.02 average hourly wage baseline.
Looking ahead
Worth watching: Whether August's slowdown to 100 jobs added becomes a trend or a one-month blip will shape confidence in Mankato as a stable site for R&D or quality headcount expansion. A second weak month would support more conservative local hiring plans.
Emerging pressure point: Minnesota's labor-force participation rate has declined every month of 2026, now at 66.9% versus 68.1% a year ago. Continued erosion narrows the candidate pool for credential-driven manufacturing and quality roles that Mankato-based life sciences employers depend on.
Early indicator: National life sciences job postings rose 20.7% year-over-year in Q2 with pharma manufacturing up 20.8%, a recovery pattern that has not yet shown up distinctly in Mankato metro data. Watch whether this demand surge reaches Minnesota's secondary markets or stays concentrated in the Twin Cities.
Potential inflection point: Minnesota WARN notices affected 69% fewer workers in 2026 than 2025, suggesting limited displaced-talent inflow to absorb. Combined with regional biotech recruiting intensity (64% of surveyed orgs actively hiring), this points to continued competition rather than relief for specialized roles.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.